SI-BONE Medical (SIBN) Enterprise Value to EBITDA Ratio
Orthopedic surgeons' flawless trust in the iFuse system is confirmed by the historical EV/EBITDA chart of SI-BONE, Inc. (SIBN), where 0.00 serves as the current parameter value. The business is based on proprietary minimally invasive treatment protocols, strictly tying clinics to its tools. High physician loyalty and Medicare support ensure one hundred percent customer retention, stimulating the influx of new procedures.
Comprehensive metric breakdowns and analytics for si-bone.com (SIBN)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
- financial results and valuation multiples details:
SIBN - Net Financial Result|Projected Future Earnings SI-BONE, Inc.|SIBN - Price to Earnings Ratio|Forward P/E Multiple SI-BONE, Inc.|SIBN - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SI-BONE Medical|SIBN - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months SI-BONE|SIBN - Earnings per share for the trailing year|Quarterly EPS earnings growth si-bone.com|SIBN - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year SI-BONE, Inc.
Analysis of all company metrics:SI-BONE Corp SIBN
To build a high-quality portfolio, I utilize EV/EBITDA, which compares the total enterprise value (market capitalization plus net debt) with operating profit before depreciation and amortization. For SI-BONE, Inc. (SIBN), a monopolist in the minimally invasive joint fixation niche, this calculation eliminates debt noise; therefore, the company's EV/EBITDA multiple chart serves as an accurate indicator of whether the market is overpaying for its dominance.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs Inc|BBNX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation IRMD|EMBC (Embecta) - EV/EBITDA Multiple|Tandem Diabetes Care Inc (TNDM) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AXGN|Enterprise Value to EBITDA Ratio Orthofix Corp OFIX|EV/EBITDA Multiple BVS (Bioventus Inc.)|EV/EBITDA Multiple OrthoPediatrics Corp KIDS|TMCI - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CARL (Carlsmed Corp) - Enterprise Value to EBITDA Ratio|RxSight Ophthalmic - Business Value to Operating Income Before Depreciation|CLPT (ClearPoint Neuro Inc.) - EV/EBITDA Multiple|Company Value to EBITDA stereotaxis.com STXS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Neuronetics (STIM)|Sight Sciences Inc. (SGHT) - Enterprise Value to EBITDA Multiple|Orchestra BioMed - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Anika Therapeutics Inc. ANIK|InspireMD, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Jin Medical International ZJYL|vivani.com (VANI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XTNT (Xtant Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NeuroOne Corp|Enterprise Value to EBITDA Ratio Modular Med (MODD)|EV/EBITDA Multiple MYO|COCH - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vivos Therapeutics, Inc. VVOS|NVNO: Enterprise Value to Operating Income Before Depreciation|SINT: Enterprise Value to EBITDA Ratio|Tenon Medical Inc - Enterprise Value to Operating Income Before Depreciation Ratio|ReWalk Robotics Ltd. (LFWD) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|AMIX - Total Company Value to Operating Income Before Depreciation Ratio|IVF (INVO Fertility) - EV/EBITDA Multiple|Bone Biologics Corp. (BBLG) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio AXNX (Axonics Modulation Technologies)|Biolase Inc. (BIOL) - Enterprise Value to EBITDA Multiple|EV/EBITDA Multiple DYNT (Dynatronics)|Paragon 28 Inc. - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|INVO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
